ACS Medicinal Chemistry Letters · 2014 · 17 citations · 10 references
MedicineCell BiologyMedicinal ChemistryBone MetabolismCell SignalingMolecular ImagingBone FormationBone TissueFluorescence ImagingFluorescence MicroscopyOsteoclast BiologyOsteoclast FunctionFluorescence ProbesFluorescent Chemical ProbesFluorescent LabelingFluorescent ProbesOsteoclast PrecursorsProtein Subcellular LocalizationRankl-mediated OsteoclastogenesisSubcellular Protein Localization
Labeling of a small bioactive molecule with fluorescent probe has been becoming an essential tool in cell biology to reveal the subcellular distribution and the location of a molecular target. QOA-8a is a novel molecule with potent antiosteoporotic effect in vivo. To investigate the molecular mechanism of QOA-8a, novel fluorescence-tagged chemical probes as bioactive as their parent molecule were designed and synthesized. The fluorescent compound 12 showed a more potent inhibitory activity on RANKL-induced osteoclastogenesis at 2 μM compared with that of QOA-8a. Microscopy experiments revealed that almost all of probe 12 accumulated in the fusing region, with little in the osteoclast precursors or the mature osteoclasts during osteoclast formation. The result suggests the location of the binding target of QOA-8a, which might greatly narrow down the search field of the target protein(s).
10
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Yoshihiko Kotake, Koji Sagane, Takashi Owa et al. · Nature Chemical Biology · 2007 · 659 citations · Full text
David L. Kendler, Christian Roux, Claude Laurent Benhamou et al. · Journal of Bone and Mineral Research · 2009 · 451 citations · Full text